US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Abivax S.A.

106.14

+3.913.82%

Volume:284.89K

Turnover:30.00M

Market Cap:9.24B

PE:-20.35

High:106.42

Open:104.56

Low:104.15

Close:102.23

52wk High:148.83

52wk Low:69.81

Shares:87.05M

Float Shares:76.46M

Volume Ratio:1.07

T/O Rate:0.37%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.2168

EPS(LYR):-5.6758

ROE:-157.07%

ROA:-44.65%

PB:18.72

PE(LYR):-18.70

Loading ...

Overview Company News Filings

Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 43.05%, and institutional views are mostly bullish

Unusually active option classes on open September 16th

Calendar of U.S. Earnings Expected in the Week Ahead

Movement Alert｜Abivax S.A. Falls 5.33% in Regular Trading, Upcoming Earnings Forecast Points to Over 40% Revenue Decline

Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings

U.S. Research Roundup-Caseys General Stores, Targa Resources, United Rentals

Abivax Sa: Shares up 2.8% After Gs Initiates at 'Buy'

THOMSON REUTERS

Abivax Sa : Goldman Sachs Initiates Coverage with Buy Rating

THOMSON REUTERS

Abivax initiated with a Buy at Goldman Sachs

Abivax Announces Positive Pre-Nda Interaction with the FDA for Obefazimod

THOMSON REUTERS

Abivax Sa: Remains on Track to Submit First Nda for Obefazimod for Treatment of Moderately to Severely Active Ulcerative Colitis by End of 2026

THOMSON REUTERS

Movement Alert｜Abivax S.A. Rises 5.18% in Regular Trading, Morgan Stanley Raises Target Price to $180

Abivax's Potential Colitis Drug Showing Positive Results That Bolster Stock Prospects, Morgan Stanley Says

MT Newswires Live

Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating

MT Newswires Live

Abivax Names New Global Heads of Marketing, Sales and Market Access in Commercial Leadership Shake-up

Abivax re-engages Centerview amid renewed takeover interest, La Lettre says

Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies

MT Newswires Live

Abivax price target raised to $175 from $165 at Piper Sandler

Abivax Closes $920 Million ADS Offering

MT Newswires Live

Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/ABVX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVX\",,,,,undefined,":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":106.14,"timestamp":1789656090761,"preClose":102.23,"halted":0,"volume":284890,"delay":0,"changeRate":0.03824708989533401,"floatShares":76455400,"shares":87054500,"eps":-5.216782,"marketStatus":"Trading","change":3.91,"latestTime":"09-17 10:41:34 EDT","open":104.56,"high":106.4229,"low":104.15,"amount":29995196.336600002,"amplitude":0.022233,"askPrice":106.26,"askSize":25,"bidPrice":106.04,"bidSize":110,"shortable":3,"etf":0,"ttmEps":-5.216782,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1697774400000,"exchange":"NASDAQ","adjPreClose":102.23,"preHourTrading":{"tag":"盘前","latestPrice":104.76,"preClose":102.23,"latestTime":"09:29 EDT","volume":17987,"amount":1870573.89356,"timestamp":1789651799083,"change":2.53,"changeRate":0.024748,"amplitude":0.023574},"postHourTrading":{"tag":"盘后","latestPrice":102.5,"preClose":102.23,"latestTime":"19:48 EDT","volume":7112,"amount":727194.3925,"timestamp":1789602517230,"change":0.27,"changeRate":0.002641,"amplitude":0.002641},"volumeRatio":1.065433,"impliedVol":0.9324,"impliedVolPercentile":0.576},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVX\",,,,,undefined,":{"symbol":"ABVX","floatShares":76455400,"roa":"-44.65%","roe":"-157.07%","lyrEps":-5.675825,"volumeRatio":1.065433,"shares":87054500,"dividePrice":0,"high":106.4229,"amplitude":0.022233,"preClose":102.23,"low":104.15,"week52Low":69.81,"pbRate":"18.72","psRate":"1634.30","week52High":148.83,"institutionHeld":0,"latestPrice":106.14,"committee":0.62963,"eps":-5.216782,"divideRate":0,"volume":284890,"delay":0,"ttmEps":-5.216782,"open":104.56,"prevYearClose":134.855,"prevWeekClose":118.64,"prevMonthClose":111.73,"prevQuarterClose":133.26,"fiveDayClose":115.95,"twentyDayClose":120.56,"sixtyDayClose":98.43,"earningDate":1789920000000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABVX\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"ABVX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":-1.08,"defaultRemindTime":1790020800000,"name":null,"time":"Post-Mkt","dateTimestamp":1789963200000,"actualEps":null},{"market":"US","date":"2026-05-22","symbol":"ABVX","fiscalQuarterEnding":"2026/03","expectedEps":-1.07,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1779422400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-03-23","symbol":"ABVX","fiscalQuarterEnding":"2025/12","expectedEps":-1.7,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774238400000,"reportTimeType":"post","actualEps":-1.19},{"market":"US","date":"2025-12-15","symbol":"ABVX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1765774800000,"reportTimeType":"post","actualEps":-2.45},{"market":"US","date":"2025-09-08","symbol":"ABVX","fiscalQuarterEnding":"2025/06","expectedEps":-0.9,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1757304000000,"reportTimeType":"post","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.5385,"hold":0.0769,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5385,"analysts":13,"updateTime":1789012800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABVX","date":"2026-09-16","current":-19.596372,"percent":0.349003,"low":-44.789917,"twenty":-27.420973,"median":-6.900568,"eighty":-2.661611,"high":-0.02231,"avg":-14.054786,"sd":12.019392,"marketCap":9097256532.43},"quantilePoints":[{"date":"2023-10-27","current":-7.823172,"twenty":-7.328793,"median":-6.587224,"eighty":-5.845656,"marketCap":753894810.45},{"date":"2023-11-03","current":-6.291292,"twenty":-6.250217,"median":-6.06538,"eighty":-6.010614,"marketCap":611163613.59},{"date":"2023-11-10","current":-6.503512,"twenty":-6.645905,"median":-6.346058,"eighty":-6.06538,"marketCap":637532258.17},{"date":"2023-11-17","current":-7.092251,"twenty":-6.941614,"median":-6.503512,"eighty":-6.069488,"marketCap":704987904.63},{"date":"2023-11-24","current":-6.558278,"twenty":-6.982681,"median":-6.613045,"eighty":-6.085918,"marketCap":654468961.83},{"date":"2023-12-01","current":-6.469283,"twenty":-6.777344,"median":-6.486397,"eighty":-6.085918,"marketCap":645658268.08},{"date":"2023-12-08","current":-6.667811,"twenty":-6.729423,"median":-6.558278,"eighty":-6.270755,"marketCap":658292574.17},{"date":"2023-12-15","current":-6.708886,"twenty":-6.708886,"median":-6.565124,"eighty":-6.291292,"marketCap":675019398.57},{"date":"2023-12-22","current":-6.859493,"twenty":-6.749961,"median":-6.585661,"eighty":-6.304984,"marketCap":690021158.62},{"date":"2023-12-29","current":-6.722577,"twenty":-6.78282,"median":-6.609622,"eighty":-6.321414,"marketCap":681416772.26},{"date":"2024-01-05","current":-6.626736,"twenty":-6.777344,"median":-6.626736,"eighty":-6.346059,"marketCap":664561787.4},{"date":"2024-01-12","current":-6.845802,"twenty":-6.796512,"median":-6.667811,"eighty":-6.407671,"marketCap":685854313.55},{"date":"2024-01-19","current":-7.023793,"twenty":-6.859493,"median":-6.681503,"eighty":-6.435054,"marketCap":698334715.34},{"date":"2024-01-26","current":-7.986412,"twenty":-6.982718,"median":-6.681503,"eighty":-6.435054,"marketCap":792063074.67},{"date":"2024-02-02","current":-8.137618,"twenty":-7.092251,"median":-6.715732,"eighty":-6.469283,"marketCap":807847078.54},{"date":"2024-02-09","current":-7.972666,"twenty":-7.379774,"median":-6.743115,"eighty":-6.503512,"marketCap":785337680.3},{"date":"2024-02-16","current":-7.738985,"twenty":-7.738985,"median":-6.763653,"eighty":-6.503512,"marketCap":761909093.06},{"date":"2024-02-23","current":-8.385046,"twenty":-7.788813,"median":-6.78419,"eighty":-6.508989,"marketCap":829978945.38},{"date":"2024-03-01","current":-8.879901,"twenty":-7.848771,"median":-6.818419,"eighty":-6.548694,"marketCap":878391233.38},{"date":"2024-03-08","current":-8.921139,"twenty":-7.986412,"median":-6.859493,"eighty":-6.569232,"marketCap":892211380.33},{"date":"2024-03-15","current":-8.659965,"twenty":-8.228342,"median":-6.982681,"eighty":-6.577447,"marketCap":863166780.31},{"date":"2024-03-22","current":-9.319772,"twenty":-8.319065,"median":-7.010102,"eighty":-6.584292,"marketCap":926107447.06},{"date":"2024-03-28","current":-9.209804,"twenty":-8.585737,"median":-7.078559,"eighty":-6.597984,"marketCap":910336135.23},{"date":"2024-04-05","current":-9.732151,"twenty":-8.736943,"median":-7.311316,"eighty":-6.610307,"marketCap":967400801.65},{"date":"2024-04-12","current":-5.879845,"twenty":-8.706701,"median":-7.078559,"eighty":-6.566493,"marketCap":928230894.29},{"date":"2024-04-19","current":-6.030284,"twenty":-8.692955,"median":-6.99641,"eighty":-6.48982,"marketCap":950004364.47},{"date":"2024-04-26","current":-6.311356,"twenty":-8.670962,"median":-6.941624,"eighty":-6.433272,"marketCap":998864220.67},{"date":"2024-05-03","current":-5.987697,"twenty":-8.585737,"median":-6.859493,"eighty":-6.311356,"marketCap":946423801.22},{"date":"2024-05-10","current":-5.698107,"twenty":-8.470271,"median":-6.80815,"eighty":-6.289097,"marketCap":907055615.77},{"date":"2024-05-17","current":-5.502208,"twenty":-8.401541,"median":-6.777344,"eighty":-6.21545,"marketCap":883582818.48},{"date":"2024-05-24","current":-5.348896,"twenty":-8.33556,"median":-6.749961,"eighty":-6.06538,"marketCap":855336978.03},{"date":"2024-05-31","current":-5.357413,"twenty":-8.297072,"median":-6.736269,"eighty":-6.030284,"marketCap":858278233.57},{"date":"2024-06-07","current":-5.493691,"twenty":-8.288824,"median":-6.708886,"eighty":-5.988933,"marketCap":883175015.23},{"date":"2024-06-14","current":-5.042271,"twenty":-8.277827,"median":-6.681503,"eighty":-5.938296,"marketCap":801878490.85},{"date":"2024-06-21","current":-5.510725,"twenty":-8.253084,"median":-6.681503,"eighty":-5.777439,"marketCap":872433075.44},{"date":"2024-06-28","current":-4.974132,"twenty":-8.244837,"median":-6.681503,"eighty":-5.74004,"marketCap":786723361.52},{"date":"2024-07-05","current":-5.306309,"twenty":-8.203599,"median":-6.667811,"eighty":-5.629968,"marketCap":847517911.35},{"date":"2024-07-12","current":-5.408517,"twenty":-8.118374,"median":-6.619891,"eighty":-5.595899,"marketCap":868631706.71},{"date":"2024-07-15","current":-5.417034,"twenty":-8.099129,"median":-6.613045,"eighty":-5.590788,"marketCap":873513053.92},{"date":"2024-08-02","current":-4.676203,"twenty":-8.079885,"median":-6.609622,"eighty":-5.583974,"marketCap":745105907.03},{"date":"2024-08-09","current":-4.513478,"twenty":-8.008406,"median":-6.578816,"eighty":-5.515836,"marketCap":727494223.22},{"date":"2024-08-16","current":-4.316495,"twenty":-7.986412,"median":-6.534318,"eighty":-5.490284,"marketCap":700482151.8},{"date":"2024-08-23","current":-4.453526,"twenty":-7.978164,"median":-6.503512,"eighty":-5.44429,"marketCap":730827498.61},{"date":"2024-08-30","current":-4.898879,"twenty":-7.906686,"median":-6.449861,"eighty":-5.413627,"marketCap":801684090.61},{"date":"2024-09-06","current":-4.667638,"twenty":-7.862699,"median":-6.432827,"eighty":-5.36082,"marketCap":764519824.83},{"date":"2024-09-13","current":-3.822511,"twenty":-7.855735,"median":-6.332367,"eighty":-5.335268,"marketCap":748409890.75},{"date":"2024-09-20","current":-3.623827,"twenty":-7.841256,"median":-6.30817,"eighty":-5.285867,"marketCap":716147844.73},{"date":"2024-09-27","current":-3.630961,"twenty":-7.835207,"median":-6.291292,"eighty":-5.156403,"marketCap":720043812.45},{"date":"2024-10-04","current":-3.210083,"twenty":-7.830393,"median":-6.281546,"eighty":-4.898879,"marketCap":627325694.46},{"date":"2024-10-11","current":-2.96041,"twenty":-7.805992,"median":-6.132492,"eighty":-4.671064,"marketCap":573856377.14},{"date":"2024-10-18","current":-3.434789,"twenty":-7.774725,"median":-6.075649,"eighty":-4.6094,"marketCap":659899758.53},{"date":"2024-10-25","current":-3.324219,"twenty":-7.75548,"median":-6.033455,"eighty":-4.49121,"marketCap":637070240.87},{"date":"2024-10-31","current":-3.438356,"twenty":-7.738985,"median":-6.030284,"eighty":-4.463804,"marketCap":662378132.46},{"date":"2024-11-08","current":-3.427655,"twenty":-7.738985,"median":-5.993854,"eighty":-4.429546,"marketCap":655972131.38},{"date":"2024-11-15","current":-3.106647,"twenty":-7.711493,"median":-5.970662,"eighty":-4.328485,"marketCap":583153684.93},{"date":"2024-11-22","current":-3.010345,"twenty":-7.590528,"median":-5.940851,"eighty":-3.765459,"marketCap":560275247.04},{"date":"2024-11-29","current":-2.837956,"twenty":-7.546541,"median":-5.882667,"eighty":-3.688029,"marketCap":531199944.09},{"date":"2024-12-06","current":-2.848666,"twenty":-7.379774,"median":-5.732176,"eighty":-3.623827,"marketCap":534218918.72},{"date":"2024-12-13","current":-2.548806,"twenty":-7.311316,"median":-5.65552,"eighty":-3.566759,"marketCap":474325506.61},{"date":"2024-12-20","current":-2.520248,"twenty":-7.311316,"median":-5.604416,"eighty":-3.452623,"marketCap":464239022.01},{"date":"2024-12-27","current":-2.516678,"twenty":-7.267503,"median":-5.595899,"eighty":-3.437643,"marketCap":465029850.03},{"date":"2025-01-03","current":-2.49883,"twenty":-7.157971,"median":-5.578864,"eighty":-3.421948,"marketCap":454676281.41},{"date":"2025-01-10","current":-2.309632,"twenty":-7.081298,"median":-5.52776,"eighty":-3.400548,"marketCap":421851498.87},{"date":"2025-01-17","current":-2.156736,"twenty":-7.048438,"median":-5.506467,"eighty":-3.355607,"marketCap":393925230.6},{"date":"2025-01-24","current":-2.178161,"twenty":-7.018316,"median":-5.493691,"eighty":-3.318513,"marketCap":402353167.1},{"date":"2025-01-31","current":-2.156736,"twenty":-6.993672,"median":-5.459621,"eighty":-3.135894,"marketCap":398893952.88},{"date":"2025-02-07","current":-2.038902,"twenty":-6.982711,"median":-5.442586,"eighty":-3.053859,"marketCap":375339390.95},{"date":"2025-02-14","current":-2.431685,"twenty":-6.966258,"median":-5.417034,"eighty":-3.014625,"marketCap":450591803.66},{"date":"2025-02-21","current":-2.725249,"twenty":-6.900568,"median":-5.408517,"eighty":-2.924742,"marketCap":505993414.61},{"date":"2025-02-28","current":-2.478798,"twenty":-6.859493,"median":-5.361671,"eighty":-2.877224,"marketCap":457649034.34},{"date":"2025-03-07","current":-2.62524,"twenty":-6.859493,"median":-5.348896,"eighty":-2.848666,"marketCap":504421902.75},{"date":"2025-03-14","current":-1.950178,"twenty":-6.845802,"median":-5.331861,"eighty":-2.792772,"marketCap":375893933.73},{"date":"2025-03-21","current":-2.425222,"twenty":-6.818419,"median":-5.306309,"eighty":-2.725249,"marketCap":466899893.66},{"date":"2025-03-28","current":-2.16502,"twenty":-6.797881,"median":-5.23817,"eighty":-2.643099,"marketCap":411881933.29},{"date":"2025-04-04","current":-1.798189,"twenty":-6.791035,"median":-5.118927,"eighty":-2.598783,"marketCap":350804145.45},{"date":"2025-04-11","current":-1.7874,"twenty":-6.777344,"median":-4.936505,"eighty":-2.541667,"marketCap":352326323.68},{"date":"2025-04-17","current":-1.884502,"twenty":-6.777344,"median":-4.813235,"eighty":-2.527388,"marketCap":377676205.37},{"date":"2025-04-25","current":-2.187427,"twenty":-6.755438,"median":-4.676203,"eighty":-2.49883,"marketCap":437738722.61},{"date":"2025-05-02","current":-2.334934,"twenty":-6.749961,"median":-4.641945,"eighty":-2.473083,"marketCap":464043181.1},{"date":"2025-05-09","current":-2.219807,"twenty":-6.744484,"median":-4.599123,"eighty":-2.430392,"marketCap":441113036.42},{"date":"2025-05-16","current":-1.936126,"twenty":-6.732161,"median":-4.504914,"eighty":-2.406016,"marketCap":381685399.33},{"date":"2025-05-23","current":-1.820966,"twenty":-6.723946,"median":-4.470655,"eighty":-2.350016,"marketCap":362101694.69},{"date":"2025-05-30","current":-1.900139,"twenty":-6.714362,"median":-4.462091,"eighty":-2.329767,"marketCap":380507035.56},{"date":"2025-06-06","current":-2.513168,"twenty":-6.708886,"median":-4.444961,"eighty":-2.329767,"marketCap":534533766.17},{"date":"2025-06-13","current":-1.97798,"twenty":-6.692456,"median":-4.410704,"eighty":-2.276706,"marketCap":425231303.24},{"date":"2025-06-20","current":-1.793505,"twenty":-6.681503,"median":-4.342188,"eighty":-2.264946,"marketCap":382035064.22},{"date":"2025-06-27","current":-2.138541,"twenty":-6.681503,"median":-4.299366,"eighty":-2.248589,"marketCap":464697383.01},{"date":"2025-07-03","current":-2.289493,"twenty":-6.681503,"median":-3.786854,"eighty":-2.248786,"marketCap":500190485.77},{"date":"2025-07-11","current":-2.429597,"twenty":-6.678765,"median":-3.702296,"eighty":-2.250599,"marketCap":527449091.87},{"date":"2025-07-18","current":-2.945587,"twenty":-6.667811,"median":-3.641661,"eighty":-2.25491,"marketCap":634057320.66},{"date":"2025-07-25","current":-23.061864,"twenty":-6.681503,"median":-3.652361,"eighty":-2.257399,"marketCap":5041932651.84},{"date":"2025-08-01","current":-24.891124,"twenty":-6.708886,"median":-3.72013,"eighty":-2.264403,"marketCap":5288723102.26},{"date":"2025-08-08","current":-24.565749,"twenty":-6.748592,"median":-3.822511,"eighty":-2.266806,"marketCap":5307007573.85},{"date":"2025-08-15","current":-24.412019,"twenty":-6.788297,"median":-4.320777,"eighty":-2.26785,"marketCap":5283013491.79},{"date":"2025-08-22","current":-27.056654,"twenty":-6.856755,"median":-4.350753,"eighty":-2.269596,"marketCap":5836300408.78},{"date":"2025-08-29","current":-27.951762,"twenty":-6.982711,"median":-4.432115,"eighty":-2.275271,"marketCap":6054693876.38},{"date":"2025-09-05","current":-31.125324,"twenty":-7.064868,"median":-4.453526,"eighty":-2.278142,"marketCap":6729569738.1},{"date":"2025-09-12","current":-27.34583,"twenty":-7.311316,"median":-4.470655,"eighty":-2.289493,"marketCap":6274864374.63},{"date":"2025-09-19","current":-27.152436,"twenty":-7.738985,"median":-4.492066,"eighty":-2.306579,"marketCap":6253253490.1},{"date":"2025-09-26","current":-27.191115,"twenty":-7.780223,"median":-4.581994,"eighty":-2.309632,"marketCap":6202939418.56},{"date":"2025-10-03","current":-27.92601,"twenty":-7.845289,"median":-4.624816,"eighty":-2.312121,"marketCap":6384002898.09},{"date":"2025-10-10","current":-30.594839,"twenty":-7.986412,"median":-4.667638,"eighty":-2.323665,"marketCap":6912424239.13},{"date":"2025-10-17","current":-30.362767,"twenty":-8.220094,"median":-4.710461,"eighty":-2.327411,"marketCap":6924043391.69},{"date":"2025-10-24","current":-30.633518,"twenty":-8.30257,"median":-4.898879,"eighty":-2.331337,"marketCap":6947674791.64},{"date":"2025-10-31","current":-35.158924,"twenty":-8.659965,"median":-5.080599,"eighty":-2.331337,"marketCap":7943607628.35},{"date":"2025-11-07","current":-34.191957,"twenty":-8.769933,"median":-5.221135,"eighty":-2.334934,"marketCap":7707312075.45},{"date":"2025-11-14","current":-36.435321,"twenty":-8.934885,"median":-5.289274,"eighty":-2.340751,"marketCap":8287572122.24},{"date":"2025-11-21","current":-39.68433,"twenty":-9.168566,"median":-5.331861,"eighty":-2.344168,"marketCap":8947428940.69},{"date":"2025-11-28","current":-41.772979,"twenty":-9.226299,"median":-5.340378,"eighty":-2.351863,"marketCap":9466410187.89},{"date":"2025-12-05","current":-36.473999,"twenty":-9.286782,"median":-5.354345,"eighty":-2.35938,"marketCap":8310882570.26},{"date":"2025-12-12","current":-41.850337,"twenty":-9.520464,"median":-5.382965,"eighty":-2.371798,"marketCap":9611017354.25},{"date":"2025-12-19","current":-26.516104,"twenty":-20.549981,"median":-5.417034,"eighty":-2.383656,"marketCap":9139275129.17},{"date":"2025-12-26","current":-32.349646,"twenty":-23.956328,"median":-5.429811,"eighty":-2.389415,"marketCap":11186696717.72},{"date":"2026-01-02","current":-30.493519,"twenty":-24.259916,"median":-5.455362,"eighty":-2.392505,"marketCap":10512635312.43},{"date":"2026-01-09","current":-26.250942,"twenty":-24.408436,"median":-5.485173,"eighty":-2.400028,"marketCap":8979345802.35},{"date":"2026-01-16","current":-27.099458,"twenty":-24.671496,"median":-5.49795,"eighty":-2.410756,"marketCap":9234075745.3},{"date":"2026-01-23","current":-28.266166,"twenty":-24.923661,"median":-5.514984,"eighty":-2.41264,"marketCap":9748190743.74},{"date":"2026-01-30","current":-25.137266,"twenty":-25.338253,"median":-5.570347,"eighty":-2.413186,"marketCap":8803591875.67},{"date":"2026-02-06","current":-25.694104,"twenty":-25.420854,"median":-5.59164,"eighty":-2.415525,"marketCap":8892505001.77},{"date":"2026-02-13","current":-28.160102,"twenty":-25.842594,"median":-5.604416,"eighty":-2.424554,"marketCap":9808417129.46},{"date":"2026-02-20","current":-29.8041,"twenty":-26.038814,"median":-5.612933,"eighty":-2.425222,"marketCap":10293092752.09},{"date":"2026-02-27","current":-27.205522,"twenty":-26.533578,"median":-5.732176,"eighty":-2.429597,"marketCap":9418925305.5},{"date":"2026-03-06","current":-24.925137,"twenty":-26.516104,"median":-5.879845,"eighty":-2.431685,"marketCap":8459789891.3},{"date":"2026-03-13","current":-26.834297,"twenty":-26.533578,"median":-5.940851,"eighty":-2.439509,"marketCap":9079426835.73},{"date":"2026-03-20","current":-29.008617,"twenty":-26.834297,"median":-5.970662,"eighty":-2.463662,"marketCap":9819639406.07},{"date":"2026-03-27","current":-21.015395,"twenty":-26.834297,"median":-5.993854,"eighty":-2.464511,"marketCap":8146846911.19},{"date":"2026-04-02","current":-23.889698,"twenty":-26.791871,"median":-6.021767,"eighty":-2.473083,"marketCap":9269655072.73},{"date":"2026-04-10","current":-25.421089,"twenty":-26.781265,"median":-6.033455,"eighty":-2.478084,"marketCap":9995412686.01},{"date":"2026-04-17","current":-24.667173,"twenty":-26.643534,"median":-6.075649,"eighty":-2.488644,"marketCap":9762937178.52},{"date":"2026-04-24","current":-22.617465,"twenty":-26.548683,"median":-6.132492,"eighty":-2.497285,"marketCap":8904504345.79},{"date":"2026-05-01","current":-22.723485,"twenty":-26.519599,"median":-6.281546,"eighty":-2.49883,"marketCap":8959888176.91},{"date":"2026-05-08","current":-24.855652,"twenty":-26.431252,"median":-6.291292,"eighty":-2.49883,"marketCap":9832902989.64},{"date":"2026-05-15","current":-23.336041,"twenty":-26.388826,"median":-6.30817,"eighty":-2.5103,"marketCap":9155235319.25},{"date":"2026-05-22","current":-25.110387,"twenty":-26.341097,"median":-6.332367,"eighty":-2.515976,"marketCap":9778300609.43},{"date":"2026-05-29","current":-27.204576,"twenty":-26.452465,"median":-6.430599,"eighty":-2.51882,"marketCap":10531826440.97},{"date":"2026-06-05","current":-21.07515,"twenty":-26.452465,"median":-6.449861,"eighty":-2.524532,"marketCap":8138996627.53},{"date":"2026-06-12","current":-20.403432,"twenty":-26.394129,"median":-6.503512,"eighty":-2.527388,"marketCap":7810578705.92},{"date":"2026-06-18","current":-20.679316,"twenty":-26.366489,"median":-6.510358,"eighty":-2.527388,"marketCap":7884389896.71},{"date":"2026-06-26","current":-20.271488,"twenty":-26.33676,"median":-6.575393,"eighty":-2.530811,"marketCap":7666425554.42},{"date":"2026-07-02","current":-30.659126,"twenty":-26.404736,"median":-6.59593,"eighty":-2.53709,"marketCap":11655941374.46},{"date":"2026-07-10","current":-31.890615,"twenty":-26.746832,"median":-6.626736,"eighty":-2.543095,"marketCap":12110267741.2},{"date":"2026-07-17","current":-30.930523,"twenty":-26.834297,"median":-6.667811,"eighty":-2.55052,"marketCap":11755084937.65},{"date":"2026-07-24","current":-29.269824,"twenty":-26.959814,"median":-6.681503,"eighty":-2.564944,"marketCap":11055640094.37},{"date":"2026-07-31","current":-27.583176,"twenty":-27.075079,"median":-6.681503,"eighty":-2.595213,"marketCap":10549310515.77},{"date":"2026-08-07","current":-29.607153,"twenty":-27.191115,"median":-6.715732,"eighty":-2.598783,"marketCap":11333828453.56},{"date":"2026-08-14","current":-26.649033,"twenty":-27.205522,"median":-6.743115,"eighty":-2.618096,"marketCap":10213208013.38},{"date":"2026-08-21","current":-28.220286,"twenty":-27.205522,"median":-6.763653,"eighty":-2.62524,"marketCap":10949286420.23},{"date":"2026-08-28","current":-27.431695,"twenty":-27.34583,"median":-6.791035,"eighty":-2.632383,"marketCap":10616040493.94},{"date":"2026-09-04","current":-27.488023,"twenty":-27.431695,"median":-6.83211,"eighty":-2.643099,"marketCap":10613111685.26},{"date":"2026-09-11","current":-26.578494,"twenty":-27.424889,"median":-6.859493,"eighty":-2.653339,"marketCap":10266716010.47},{"date":"2026-09-16","current":-23.731735,"twenty":-27.420973,"median":-6.900568,"eighty":-2.661611,"marketCap":9097256532.43}],"updateTime":1789644125160},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABVX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1164815003","title":"Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 43.05%, and institutional views are mostly bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1164815003","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1164815003?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:04","pubTimestamp":1789344246,"startTime":"0","endTime":"0","summary":"Abstract Abivax S.A. is scheduled to release quarterly results on September 21, 2026 Post-Mkt, with investor attention on loss trajectory, operating runway after the mid-year equity raise, and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 43.05%, and institutional views are mostly bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667986712","title":"Unusually active option classes on open September 16th","url":"https://stock-news.laohu8.com/highlight/detail?id=2667986712","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667986712?lang=en_us&edition=fundamental","pubTime":"2026-09-16 21:40","pubTimestamp":1789566021,"startTime":"0","endTime":"0","summary":"Unusual total active option classes on open include: ADT (ADT), Carnival (CCL), AGNC Investment Corp. (AGNC), Fly Leasing Ltd (FLY), Abivax (ABVX),...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-september-16th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-september-16th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4110","CCL","ADT","CRDT","BK4585","BK4139","FLY","BK4547","WSPC","AGNC","FLYT","BK4517","BK4165","BK4142","MORT","ABVX","BK4588","BK4615","REM","DVDN","BK4187","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667604460","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2667604460","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667604460?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:00","pubTimestamp":1789552800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·Thor Indus Inc.                                  4Q       .90   6:30 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBH","BK4104","LU1221951046.USD","DAVA","APOG","LEN","LU0234570918.USD","LU2041044095.USD","XHB","LU2125910179.SGD","TBLU","BK4088","AMC","BK4596","LU0320765489.SGD","LU0314106906.USD","LU1571399168.USD","BK4517","BK4142","LU0345770993.USD","LU0130102774.USD","LU0208291251.USD","BK4139","BK4588","CCL","LEN.B","ITB","AZO","LU1923621640.USD","BK4143","LU1506573853.SGD","ABVX","LU2125910336.SGD","BK4094","LU0070302665.USD","BK4559","BK4161","LU0648001328.SGD","LU1721427968.SGD","THO","LUXE","LU1032955483.USD","AQWA","FERG","WOR","LU1934455863.HKD","VFS","LU1037948897.HKD","MLKN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149843236","title":"Movement Alert｜Abivax S.A. Falls 5.33% in Regular Trading, Upcoming Earnings Forecast Points to Over 40% Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1149843236","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149843236?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:06","pubTimestamp":1789481174,"startTime":"0","endTime":"0","summary":"On September 15, Abivax S.A. fell 5.33% in regular trading, trading at $107.11/share, with turnover of approximately $32.65 million. The selloff appears driven by investor caution ahead of the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Abivax Falls as Revenue Expected to Decline Over 40%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667651503","title":"Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667651503","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667651503?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:55","pubTimestamp":1789376108,"startTime":"0","endTime":"0","summary":"Abivax will report H1 earnings Sept. 21; analysts expect a $1.08 loss/share and $1.86M revenue.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/09/61757828/abivax-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666636615","title":"U.S. Research Roundup-Caseys General Stores, Targa Resources, United Rentals","url":"https://stock-news.laohu8.com/highlight/detail?id=2666636615","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666636615?lang=en_us&edition=fundamental","pubTime":"2026-09-10 15:23","pubTimestamp":1789024986,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United RentalsSept 10 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL4N4520I0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COIA","AU","HP","CLDX","AEO","CNM","AVAV","IEZ","BCRX","AWK","EAT","CHRD","EOG","DRLL","CRC","AVGW","AAL","AMD","CON","COIN","AEHR","DAL","TRFK","FANG","CPG.UK","BKR","CASY","DPZ","AAPL","ILDR","MASS","BG","APA","ABNB","ABVX","XYZ","CLOV","ET","PXJ","AVGO","COP","AMDL","ASO","DVN","ALK","EQT","AZO","AR","COIO","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666217568","title":"Abivax Sa: Shares up 2.8% After Gs Initiates at 'Buy'","url":"https://stock-news.laohu8.com/highlight/detail?id=2666217568","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666217568?lang=en_us&edition=fundamental","pubTime":"2026-09-10 15:01","pubTimestamp":1789023704,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN45115F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666502725","title":"Abivax Sa : Goldman Sachs Initiates Coverage with Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666502725","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666502725?lang=en_us&edition=fundamental","pubTime":"2026-09-10 14:27","pubTimestamp":1789021657,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN452049:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666301955","title":"Abivax initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2666301955","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666301955?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:35","pubTimestamp":1788986159,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Abivax (ABVX) with a Buy rating and $155 price target Key pipeline asset obefazimod is “uniquely positioned” an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0004086264.USD","LU0210536198.USD","LU2750360641.GBP","BK4139","LU1144417596.USD","IE00B19Z3B42.SGD","LU1868837136.USD","IE0034235188.USD","GSX","LU0868494617.USD","IE0002270589.USD","BK4516","LU2237438978.USD","LU2471134523.USD","BK4533","LU2237443549.SGD","BK4552","LU2237443622.USD","LU0345770993.USD","LU0345770308.USD","LU0942090050.USD","LU1791807156.HKD","LU1804176565.USD","IE0004091025.USD","LU2471134879.HKD","LU1868836757.USD","ABVX","LU2237443382.USD","LU2237443978.SGD","LU2471134796.USD","LU0048573561.USD","LU0096364046.USD","BK4588","LU2471134952.CNY","LU1894683348.USD","LU2750360997.AUD","LU0742534661.SGD","BK4504","LU1894683264.USD","LU0061475181.USD","BK4585","IE00B19Z3581.USD","LU1868836591.USD","LU1868837300.USD","IE00BFXG1179.USD","BK4127","LU0106831901.USD","LU0251142724.SGD","LU2896262040.SGD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655601383","title":"Abivax Announces Positive Pre-Nda Interaction with the FDA for Obefazimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2655601383","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655601383?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:05","pubTimestamp":1785441907,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W2KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655383141","title":"Abivax Sa: Remains on Track to Submit First Nda for Obefazimod for Treatment of Moderately to Severely Active Ulcerative Colitis by End of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655383141","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655383141?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:05","pubTimestamp":1785441907,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W2KF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138028006","title":"Movement Alert｜Abivax S.A. Rises 5.18% in Regular Trading, Morgan Stanley Raises Target Price to $180","url":"https://stock-news.laohu8.com/highlight/detail?id=1138028006","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138028006?lang=en_us&edition=fundamental","pubTime":"2026-07-30 23:01","pubTimestamp":1785423662,"startTime":"0","endTime":"0","summary":"On July 30, Abivax S.A. rose 5.18% in regular trading, trading at $124.4/share, with turnover of $55.49 million. The rally was driven by Morgan Stanley significantly raising its price target on the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653822600","title":"Abivax's Potential Colitis Drug Showing Positive Results That Bolster Stock Prospects, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2653822600","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653822600?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:47","pubTimestamp":1784897275,"startTime":"0","endTime":"0","summary":"Abivax's  drug obefazimod for the potential treatment of ulcerative colitis patients has shown promising clinical results, with experts seeing the potential for \"broad uptake\" of the drug in the long term, Morgan Stanley said in a note to investors on Friday.Sentiment on lingering regulatory and labeling concerns has also improved as clinical data has come in, the note said.Experts and opinion leaders were \"unanimously positive\" on obefazimod's efficacy, suggesting \"broad opportunity\" for obefazimod, the note said.The drug's benefits outweigh potential risks of overly strict labeling or long-term adverse effects, the note said.\"Clear from our conversations is the near-unanimous support for obefazimod's efficacy profile, particularly on endoscopic measures,\" the note said.Morgan Stanley rated Abivax overweight and raised its price target to between $159 and $202, from the previous $97 to $157.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653083983","title":"Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2653083983","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653083983?lang=en_us&edition=fundamental","pubTime":"2026-07-24 17:47","pubTimestamp":1784886456,"startTime":"0","endTime":"0","summary":"Abivax (ABVX) has an average rating of buy and mean price target of $162.06, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and r","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653773710","title":"Abivax Names New Global Heads of Marketing, Sales and Market Access in Commercial Leadership Shake-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2653773710","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653773710?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:13","pubTimestamp":1784837624,"startTime":"0","endTime":"0","summary":"Abivax names new global heads of marketing, sales and market access in commercial leadership shake-upAbivax expanded its commercial leadership team with four senior hires as it prepares a potential US","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL4VGb0V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652287827","title":"Abivax re-engages Centerview amid renewed takeover interest, La Lettre says","url":"https://stock-news.laohu8.com/highlight/detail?id=2652287827","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652287827?lang=en_us&edition=fundamental","pubTime":"2026-07-18 02:10","pubTimestamp":1784311814,"startTime":"0","endTime":"0","summary":"Marc de Garidel’s company suspended takeover talks with pharma giants including AstraZeneca (AZN) and Eli Lilly (LLY) last month as it secured an E...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-re-engages-centerview-amid-renewed-takeover-interest-la-lettre-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-re-engages-centerview-amid-renewed-takeover-interest-la-lettre-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651644362","title":"Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2651644362","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651644362?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:08","pubTimestamp":1784196523,"startTime":"0","endTime":"0","summary":"Valerio Therapeutics said Thursday it has entered into a binding term sheet with Abivax  for an exclusive worldwide research and development collaboration to develop next-generation therapies for immune-mediated inflammatory diseases.Under the agreement, the company said it could receive up to 2.4 million euros  upfront, along with potential development and commercial milestone payments and royalties, subject to the execution of a definitive co-ownership and license agreement.The companies will collaborate on the discovery, manufacturing and preclinical evaluation of therapeutic candidates, with Abivax retaining the option to advance selected programs into further development.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4539","BK4007","LENZ","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650926264","title":"Abivax price target raised to $175 from $165 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2650926264","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650926264?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:21","pubTimestamp":1783596090,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on Abivax (ABVX) to $175 from $165 and keeps an Overweight rating on the shares. The firm is raising i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-to-175-from-165-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-to-175-from-165-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679769","title":"Abivax Closes $920 Million ADS Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679769","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679769?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:21","pubTimestamp":1783369279,"startTime":"0","endTime":"0","summary":"Abivax  said Monday it closed its previously announced public offering of 7.36 million American depositary shares, including the full exercise of the underwriters' option to purchase additional ADSs.The offering generated aggregate gross proceeds of approximately $920 million, with estimated net proceeds of approximately $874.1 million, according to a statement.Abivax said the net proceeds, together with its current cash and cash equivalents, will fund operations into Q4 of 2029.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649281620","title":"Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2649281620","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649281620?lang=en_us&edition=fundamental","pubTime":"2026-07-06 23:12","pubTimestamp":1783350766,"startTime":"0","endTime":"0","summary":"Abivax  shares have rebounded to pre-Phase 3 maintenance data levels as investor concerns over malignancy rates eased, but obefazimod is unlikely to displace JAK inhibitors in inflammatory bowel disease, Wedbush said in a report Monday.The firm said \"malignancy rates\" associated with obefazimod's 50-milligram dose appear comparable with those seen with approved JAK inhibitors, including market leader AbbVie's  Rinvoq, suggesting the safety profile is unlikely to significantly limit commercial adoption, according to the report.However, the firm said that claims obefazimod is \"best in disease\" are not supported by the data, noting its \"induction\" efficacy in biologic-experienced patients lagged Rinvoq's, although maintenance results were broadly comparable. The analysts expect obefazimod to find a role in patients previously treated with JAK inhibitors rather than replace the class.The report also said the likelihood of a near-term acquisition has diminished, citing reduced interest from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":132,"code":"91000000","status":"200"}]}}